Identification of regulatory variants of carboxylesterase 1 (CES1): A proof‐of‐concept study for the application of the Allele‐Specific Protein Expression (ASPE) assay in identifying <i>cis</i> ‐acting regulatory genetic polymorphisms-Reference-Cited by-同舟云学术

Identification of regulatory variants of carboxylesterase 1 (CES1): A proof‐of‐concept study for the application of the Allele‐Specific Protein Expression (ASPE) assay in identifying cis ‐acting regulatory genetic polymorphisms

Published:2022-12-07 Issue:1 Volume:23 Page:2200176
ISSN:1615-9853
Container-title:PROTEOMICS
language:en
Short-container-title:Proteomics

Author:

Her Lucy¹^ORCID,Shi Jian²,Wang Xinwen³,He Bing⁴,Smith Logan S.⁵,Jiang Hui⁶,Zhu Hao‐Jie⁵^ORCID

Affiliation:

1. Eli Lilly and Company Indianapolis Indiana USA

2. Alliance Pharma, Inc Malvern Pennsylvania USA

3. Department of Pharmaceutical Sciences Northeast Ohio Medical University Rootstown Ohio USA

4. Department of Computational Medicine and Bioinformatics University of Michigan Ann Arbor Michigan USA

5. Department of Clinical Pharmacy University of Michigan Ann Arbor Michigan USA

6. Department of Biostatistics University of Michigan Ann Arbor Michigan USA

Funder

National Heart, Lung, and Blood Institute

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Publisher

Wiley

Subject

Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pmic.202200176

Reference44 articles.

1. Trans-acting genetic variation affects the expression of adjacent genes

2. From expression QTLs to personalized transcriptomics

3. The roles of cis- and trans-regulation in the evolution of regulatory incompatibilities and sexually dimorphic gene expression

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of carboxylesterases and its impact on pharmacokinetics and pharmacodynamics: an up-to-date review;Expert Opinion on Drug Metabolism & Toxicology;2024-05-03